Biomarkers Improve Clinical Outcome Predictors of Mortality Following Non-Penetrating Severe Traumatic Brain Injury

[1]  Ming Cheng Liu,et al.  Proteomic identification of biomarkers of traumatic brain injury , 2005, Expert review of proteomics.

[2]  Ewout Steyerberg,et al.  Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients , 2008, BMJ : British Medical Journal.

[3]  S. Beers,et al.  Serum biomarker concentrations and outcome after pediatric traumatic brain injury. , 2007, Journal of neurotrauma.

[4]  S. Wisniewski,et al.  Serum S100B concentrations are increased after closed head injury in children: a preliminary study. , 2002, Journal of neurotrauma.

[5]  C. Alling,et al.  Elimination of S100B and renal function after cardiac surgery. , 2000, Journal of cardiothoracic and vascular anesthesia.

[6]  R. Hayes,et al.  Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry. , 2005, Journal of neurotrauma.

[7]  S. Beers,et al.  Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. , 2012, Journal of neurotrauma.

[8]  B. Moore.  A soluble protein characteristic of the nervous system. , 1965, Biochemical and biophysical research communications.

[9]  B. Romner,et al.  Renal elimination of protein S-100beta in pigs with acute encephalopathy. , 2001, Scandinavian journal of clinical and laboratory investigation.

[10]  V. Seifert,et al.  Serum markers of brain damage and outcome prediction in patients after severe head injury. , 1999, British journal of neurosurgery.

[11]  I. Zagon,et al.  Brain spectrin: Of mice and men , 1995, Brain Research Bulletin.

[12]  Cooper Eh.  Neuron-Specific Enolase , 1994, The International journal of biological markers.

[13]  E. Cooper.  Neuron-specific enolase. , 1994, The International journal of biological markers.

[14]  M. Wiesmann,et al.  S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. , 1997, Stroke.

[15]  F. Tortella,et al.  Ubiquitin C‐terminal hydrolase‐L1 as a biomarker for ischemic and traumatic brain injury in rats , 2010, The European journal of neuroscience.

[16]  I. Kureshi,et al.  Comparison of percutaneous ventriculostomies and intraparenchymal monitor: a retrospective evaluation of 156 patients. , 1998, Acta neurochirurgica. Supplement.

[17]  Ricardo J. Flores,et al.  Proteomics - Human Diseases and Protein Functions , 2012 .

[18]  F. Tortella,et al.  Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats* , 2006, Molecular & Cellular Proteomics.

[19]  A. Gabrielli,et al.  Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. , 2011, Journal of neurotrauma.

[20]  A. Gabrielli,et al.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury* , 2010, Critical care medicine.

[21]  A. Gabrielli,et al.  αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. , 2010, Journal of neurotrauma.

[22]  C. Robertson,et al.  Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. , 2007, Journal of neurotrauma.

[23]  Eileen Maloney,et al.  A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. , 2009, Journal of neurotrauma.

[24]  T. Heinz,et al.  Predictive value of S-100B protein and neuron specific-enolase as markers of traumatic brain damage in clinical use , 2006, Brain injury.

[25]  I. Grivicich,et al.  Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males , 2006, Clinical chemistry and laboratory medicine.

[26]  B. Romner,et al.  Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. , 2000, Journal of neurotrauma.

[27]  MartinWiesmann,et al.  S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke , 1997 .

[28]  F. J. Díez-Guerra,et al.  Rapid dephosphorylation of microtubule-associated protein 2 in the rat brain hippocampus after pentylenetetrazole-induced seizures. , 1993, European journal of biochemistry.

[29]  Juan Lu,et al.  Predicting Outcome after Traumatic Brain Injury: Development and International Validation of Prognostic Scores Based on Admission Characteristics , 2008, PLoS medicine.

[30]  Low sensitivity of the anion gap as a screen to detect hyperlactatemia in critically ill patients. , 1989, Critical care medicine.

[31]  R. Hayes,et al.  Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. , 1996, Journal of neurotrauma.

[32]  H. Xiong,et al.  [Pathophysiological alterations in cultured astrocytes exposed to hypoxia/reoxygenation]. , 2000, Sheng li ke xue jin zhan [Progress in physiology].

[33]  M. Wald,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths, 2002-2006 , 2010 .

[34]  R. Hayes,et al.  Protein Biomarkers for Traumatic and Ischemic Brain Injury: From Bench to Bedside , 2011, Translational Stroke Research.

[35]  Hester F. Lingsma,et al.  Large Between-Center Differences in Outcome After Moderate and Severe Traumatic Brain Injury in the International Mission on Prognosis and Clinical Trial Design in Traumatic Brain Injury (IMPACT) Study , 2011, Neurosurgery.

[36]  T. Beems,et al.  GFAP and S100B are biomarkers of traumatic brain injury , 2010, Neurology.

[37]  A. Twijnstra,et al.  S‐100B and neuron‐specific enolase in serum of mild traumatic brain injury patients
A comparison with healthy controls , 2001, Acta neurologica Scandinavica.

[38]  F. Tortella,et al.  Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention , 2012, The journal of trauma and acute care surgery.

[39]  S. Beers,et al.  Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. , 2007, Journal of neurotrauma.

[40]  G. Tseng,et al.  Compression alters kinase and phosphatase activity and tau and MAP2 phosphorylation transiently while inducing the fast adaptive dendritic remodeling of underlying cortical neurons. , 2010, Journal of neurotrauma.

[41]  A. Gabrielli,et al.  Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury , 2012, Brain injury.

[42]  R. Hayes,et al.  106 Neuronal Biomarkers May Require Age-Adjusted Norms , 2011 .

[43]  F. Tortella,et al.  Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study , 2011, Critical care.

[44]  I. Zagon,et al.  Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells , 1986, The Journal of cell biology.

[45]  P. Kochanek,et al.  Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. , 2005, Journal of neurosurgery.

[46]  P. Jackson,et al.  The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis , 1981, Journal of the Neurological Sciences.

[47]  R. Donato,et al.  Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. , 1999, Biochimica et biophysica acta.

[48]  Kevin K W Wang,et al.  Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. , 2002, Biological chemistry.

[49]  A. Usui,et al.  S-100ao protein in blood and urine during open-heart surgery. , 1989, Clinical chemistry.

[50]  B. Kelley,et al.  Biochemical, Structural, and Biomarker Evidence for Calpain-Mediated Cytoskeletal Change After Diffuse Brain Injury Uncomplicated by Contusion , 2009, Journal of neuropathology and experimental neurology.

[51]  Michael Gaetz,et al.  The neurophysiology of brain injury , 2004, Clinical Neurophysiology.

[52]  山崎 義矩.  Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury , 1994 .

[53]  A. Gabrielli,et al.  Use of biomarkers for diagnosis and management of traumatic brain injury patients. , 2008, Expert opinion on medical diagnostics.

[54]  A. Gabrielli,et al.  alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. , 2009, Journal of neurotrauma.

[55]  R. Hayes,et al.  Biomarkers of Proteolytic Damage Following Traumatic Brain Injury , 2004, Brain pathology.

[56]  L. Papa.  Exploring the Role of Biomarkers for the Diagnosis and Management of Traumatic Brain Injury Patients , 2012 .

[57]  K. Wang,et al.  Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. , 2000, Biochemical and biophysical research communications.

[58]  A. Brawanski,et al.  Comparison of serial S-100 and NSE serum measurements after severe head injury , 2005, Acta Neurochirurgica.

[59]  S. Silvestri,et al.  End-tidal carbon dioxide is associated with mortality and lactate in patients with suspected sepsis. , 2013, The American journal of emergency medicine.

[60]  J. Provencio.  Serum S-100B protein monitoring in patients with severe traumatic brain injury , 2008 .

[61]  Kanefusa Kato,et al.  Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[62]  Jean A. Orman,et al.  The Epidemiology of Traumatic Brain Injury , 2010, The Journal of head trauma rehabilitation.

[63]  C. Robertson,et al.  Clinical Significance of αII-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury , 2007 .

[64]  A. Gabrielli,et al.  Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. , 2012, Journal of neurotrauma.